je.st
news
Regeneron Pharms Receives Neutral Rating from Zacks
2013-02-19 04:07:39| Biotech - Topix.net
's stock had its "neutral" rating reaffirmed by Zacks in a research note issued on Monday.
Tags: rating
receives
neutral
zacks
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||